It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt. An FDA advisory committee ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Get the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock news and headlines to help you in your trading and investing decisions.

This file contains two lexicons at two different borderline (B) values: B=1 and B=2. Each of our two lexicons, VERY-NEG and VERY-POS: 1- VERY-NEG which consists of a list of the most negative words ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...